Search

everythinglearnresearchcommunity

for

Search:↓

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

New understanding and treatments for hair loss are improving, but more research is needed.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

PRP is an effective and safe treatment for alopecia areata.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

HIV can cause unusual and severe skin problems that are hard to treat.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Freeze-dried dexamethasone nanoparticles in a hydrogel are stable and effective for treating alopecia areata.